Apogee Therapeutics, Inc.
APGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $141,789 | $118,316 | $151,890 |
| Short-Term Investments | $378,864 | $277,143 | $0 |
| Receivables | $4,697 | $1,214 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4,363 | $1,736 | $165 |
| Total Curr. Assets | $529,713 | $398,409 | $152,055 |
| Property Plant & Equip (Net) | $13,324 | $2,594 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $210,416 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $498 | $401 | $0 |
| Total NC Assets | $224,238 | $2,995 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $753,951 | $401,404 | $152,055 |
| Liabilities | – | – | – |
| Payables | $1,071 | $2,143 | $418 |
| Short-Term Debt | $3,234 | $1,101 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $24,255 | $17,314 | $9,562 |
| Total Curr. Liab. | $28,560 | $20,558 | $9,980 |
| LT Debt | $8,597 | $933 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $8,597 | $933 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $8,597 | $933 | $0 |
| Total Liabilities | $37,157 | $21,491 | $9,980 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $177,467 |
| Common Stock | $1 | $0 | $2,251 |
| Retained Earnings | -$305,916 | -$123,770 | -$39,785 |
| AOCI | $915 | $329 | $2,142 |
| Other Equity | $1,021,794 | $503,354 | $0 |
| Total Equity | $716,794 | $379,913 | $142,075 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $753,951 | $401,404 | $152,055 |
| Net Debt | -$129,958 | -$116,282 | -$151,890 |